Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour Caitriona CahirStephan U. DombrowskiLinda Sharp Original Article 07 March 2015 Pages: 3115 - 3130
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials Li WangOnur BaserRichard Barron Original Article Open access 29 March 2015 Pages: 3131 - 3140
Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation Diana T. NguyenSepideh ShayaniRicardo Spielberger Original Article 21 March 2015 Pages: 3141 - 3147
Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan–prognostic assessment tools validation (J-ProVal) study Tomofumi MiuraYoshihisa MatsumotoHiroya Kinoshita Original Article 17 March 2015 Pages: 3149 - 3156
Palliative care in patients with ovarian cancer and bowel obstruction Alberto DanieleA. FerreroG. Menato Original Article 25 March 2015 Pages: 3157 - 3163
Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study J. M. BowenI. WhiteD. M. K. Keefe Original Article 27 March 2015 Pages: 3165 - 3172
Evaluating the Liverpool Care Pathway for care of the terminally ill in rural Australia Anne M. WilkinsonClaire E. JohnsonTapan Rai Original Article 24 March 2015 Pages: 3173 - 3181
Chemotherapy interruptions in relation to symptom severity in advanced breast cancer Gwen WyattAlla SikorskiiGordan Srkalovic Original Article 25 March 2015 Pages: 3183 - 3191
Follow-up care practices and barriers to breast cancer survivorship: perspectives from Asian oncology practitioners Terence NgMing Ren TohAlexandre Chan Original Article 21 March 2015 Pages: 3193 - 3200
Disparities in barriers to follow-up care between African American and White breast cancer survivors Nynikka R. A. PalmerKathryn E. WeaverAnn M. Geiger Original Article 29 March 2015 Pages: 3201 - 3209
The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer Catherine L GrangerSelina M ParryLinda Denehy Original Article 26 March 2015 Pages: 3211 - 3218
Potential factors associated with perceived cognitive impairment in breast cancer survivors Jamie S. MyersJo A. WickJennifer Klemp Original Article 03 April 2015 Pages: 3219 - 3228
Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial Sameer BakhshiAtul BatraVishnubhatla Sreenivas Original Article 08 April 2015 Pages: 3229 - 3237
Exercise preferences, levels and quality of life in lung cancer survivors H. J. LeachJ. A. DevonishS. N. Culos-Reed Original Article 02 April 2015 Pages: 3239 - 3247
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients Sebastiano MercadanteFederica AielliGiampiero Porzio Original Article 03 April 2015 Pages: 3249 - 3255
The eating experience in long-term survivors of head and neck cancer: a mixed-methods study Heidi GanzerPamela Rothpletz-PugliaRiva Touger-Decker Original Article 08 April 2015 Pages: 3257 - 3268
Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy—a survey of health care providers and patients Carmel JacobsBrian HuttonMark Clemons Original Article 03 May 2015 Pages: 3269 - 3275
Chemotherapy in the last 30 days of life of advanced cancer patients Paola PacettiGiovanni PaganiniMaurizio Cantore Original Article 22 April 2015 Pages: 3277 - 3280
Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC) Bernardo RapoportDaniel ChuaLuis Enrique Fein Original Article 05 May 2015 Pages: 3281 - 3288
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC) Salvatore Giacomo MoranoRoberto LatagliataRobin Foà Original Article 26 April 2015 Pages: 3289 - 3295
Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey Cheryl VidallPaz Fernández-OrtegaFlorian Scotté Original Article Open access 08 May 2015 Pages: 3297 - 3305
A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea D. PerezK. J. SharplesM. Findlay Original Article 28 May 2015 Pages: 3307 - 3315
Palonosetron in combination with 1-day versus 3-day dexamethasone to prevent nausea and vomiting in patients receiving paclitaxel and carboplatin Naoto FurukawaSeiji KanayamaFuminori Ito Original Article 07 May 2015 Pages: 3317 - 3322
Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer Kosei KubotaWataru KobayashiHiroto Kimura Original Article 20 May 2015 Pages: 3323 - 3329
Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool Yuka MatsudaKenji OkitaKoichi Hirata Original Article 24 May 2015 Pages: 3331 - 3339
Defining optimal control of chemotherapy-induced nausea and vomiting—based on patients’ experience Catalina Hernandez TorresSasha MazzarelloMark Clemons Original Article 25 June 2015 Pages: 3341 - 3359
The course of fatigue and its correlates in colorectal cancer survivors: a prospective cohort study of the PROFILES registry Olga HussonFloortje MolsMelissa S. Y. Thong Original Article Open access 28 June 2015 Pages: 3361 - 3371
Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial Janelle YorkeMari Lloyd-WilliamsAlex Molassiotis Original Article Open access 26 June 2015 Pages: 3373 - 3384
Pre-transplant arm muscle area: a simple measure to identify patients at risk Ana Cláudia ThomazCarolline Ilha SilvérioRegina Maria Vilela Review Article 21 July 2015 Pages: 3385 - 3391
